New Paradigm of Complete Revascularization in Acute Coronary Syndrome with Multivessel Coronary Artery Disease: Is it Reasonable in Clinical Practice?

Adhika Prastya Wikananda, Mohammad Saifur Rohman, Novi Kurnianingsih, Cholid Tri Tjahjono

Abstract


Coronary artery disease is the leading cause of illness and death in older adults. Around 40% to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multiple coronary artery disease. Multiple vessel coronary disease has been shown to improve cardiac outcomes and survival in patients who have undergone complete revascularization (CR) versus patients who have undergone only incomplete revascularization (ICR). When coronary angiography and PCI of the source of the infarction are performed on patients with STEMI, the risk of adverse cardiac death or myocardial infarction is significantly reduced. Additional research is needed to determine the efficacy of PCI of non-critical lesions. However, following procedures such as CABG or PCI, these procedures may be impossible to perform due to a variety of personal, anatomical, technical, and logistical barriers. In this review, we discussed about benefit of complete revascularization in patient acute coronary syndrome (ACS) with multivessel disease and which patient can be performed aggressive revascularization to achieved CR in clinical practice.

Keywords: complete revascularization, acute coronary syndrome, percutaneous coronary intervention


Keywords


complete revascularization, acute coronary syndrome, percutaneous coronary intervention

Full Text:

PDF

References


Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, et al. Extent, location, and clinical significance of non-infarctrelated coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019–27

Voudris KV, Feldman DN. Complete Revascularization in Patients With STEMI and Multivessel Coronary Artery Disease: Is It Beneficial? Current Treatment Options in Cardiovascular Medicine. 2021 Feb;23(2):1-2.

Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van de Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong MH, andPatel MR. Extent, location, and clinical significance of non-infarctrelated coronary artery disease among patients with STelevation myocardial infarction. JAMA, 2014. 312(19): p.2019-27.

Safiullah ZN, Zhu J, Toma C, Thoma FW, Smith AJ, MARROQUIN OC, Fowler JA, Schindler JT, Mulukutla SR. Identifying Clinical Predictors of Mortality After PCI and the Impact of Complete Revascularization in Patients With Multi-vessel Coronary Artery Disease. Circulation. 2020 Nov 17;142(Suppl_3):A15087-.

Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019;381:1411–21.

Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). The American journal of cardiology. 2009 Aug 15;104(4):507-13.

Lu C, Huang H, Li J, Zhao J, Zhang Q, Zeng Z, Chen Y. Complete versus culprit-only revascularization during primary percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis. The Kaohsiung journal of medical sciences. 2013 Mar 1;29(3):140-9.

Iqbal MB, Ilsley C, Kabir T, Smith R, Lane R, Mason M, et al. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes. 2014;7:936–43

O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–425.

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. New England Journal of Medicine. 2017 Dec 21;377(25):2419-32.

Braik N, Guedeney P, Behnes M, Desch S, Barthélémy O, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Hauguel-Moreau M, Zeitouni M. Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial. American heart journal. 2021 Feb 1;232:185-93.

Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van de Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong MH, andPatel MR. Extent, location, and clinical significance of non-infarctrelated coronary artery disease among patients with STelevation myocardial infarction. JAMA, 2014. 312(19): p. 2019-27.

Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115–23.

Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. Jam Coll Cardiol. 2015;65:963–72.

Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274–81

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–71.

Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Ong PJ, Hambrecht R. Fractional flow reserve–guided multivessel angioplasty in myocardial infarction. New England Journal of Medicine. 2017 Mar 30;376(13):1234-44.

Smits PC, Laforgia PL, Abdel-Wahab M, Neumann FJ, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction: 3-year follow-up with cost benefit analysis of the Compare-Acute trial. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2020 Apr 7.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.

Bainey KR, Alemayehu W, Armstrong PW, Westerhout CM, Kaul P, Welsh RC. Long-term outcomes of complete revascularization with percutaneous coronary intervention in acute coronary syndromes. JACC: Cardiovascular Interventions. 2020 Jul 13;13(13):1557-67.

Hannan EL, Zhong Y, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB. Association of coronary vessel characteristics with outcome in patients with percutaneous coronary interventions with incomplete revascularization. JAMA cardiology. 2018 Feb 1;3(2):123-30.

Kobayashi Y, Lønborg J, Jong A, Nishi T, De Bruyne B, Høfsten DE, Kelbæk H, Layland J, Nam CW, Pijls NH, Tonino PA. Prognostic value of the residual SYNTAX score after functionally complete revascularization in ACS. Journal of the American College of Cardiology. 2018 Sep 18;72(12):1321-9.

Hwang D, Kang J, Yang HM, Yang S, Park J, Han JK, Kang HJ, Koo BK, Kim HS. Better prognosis after complete revascularization using contemporary coronary stents in patients with chronic kidney disease. Circulation: Cardiovascular Interventions. 2019 Aug;12(8):e007907.

Farooq V, Serruys PW, Bourantas CV, Zhang Y, Muramatsu T, Feldman T, Holmes DR, Mack M, Morice MC, Ståhle E, Colombo A, de Vries T, Morel MA, Dawkins KD, Kappetein AP, Mohr FW. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. 2013;128:141–151.

Flores‐Umanzor EJ, Cepas‐Guillen PL, Vázquez S, Fernandez‐Valledor A, Ivey‐Miranda J, Izquierdo M, Caldentey G, Jimenez‐Britez G, Regueiro A, Freixa X, Farrero M. Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes. Catheterization and Cardiovascular Interventions. 2021 Feb 15;97(3):376-83.

Barton GR, Irvine L, Flather M, McCann GP, Curzen N, Gershlick AH, CvLPRIT Investigators. Economic evaluation of complete revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention. Value in Health. 2017 Jun 1;20(6):745-51.

Lee KY, Ong TK, Low EV, Liow SY, Anchah L, Hamzah S, Liew HB, Ali RM, Ismail O, Ahmad WA, Said MA. Cost of elective percutaneous coronary intervention in Malaysia: a multicentre cross-sectional costing study. BMJ open. 2017 May 1;7(5):e014307.

Thomson VS, Varghese MJ, Chacko ST, Varghese L, Alex AG, George PV, George OK, Joseph G, Yadav BK, John J. Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease. Catheterization and Cardiovascular Interventions. 2020 Apr 15.




DOI: https://doi.org/10.21776/ub.hsj.2021.002.03.2

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Adhika Prastya Wikananda, Mohammad Saifur Rohman, Novi Kurnianingsih, Cholid Tri Tjahjono

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.